MedPath

Accelerating Healthcare Engagement in Healthy Food Interventions - Food Rx in High Risk Pregnant Mothers With About Fresh and Community Health Choice

Not Applicable
Recruiting
Conditions
Nutrition in High-Risk Pregnancy
Registration Number
NCT06275568
Lead Sponsor
The University of Texas Health Science Center, Houston
Brief Summary

The purpose of the study is to assess if the Fresh Connect food prescription (Fresh Connect Food Rx) program that provides consistent access to healthy fresh produce through purchases at the grocery store plus nutrition education impacts gestational weight gain, other pregnancy and birth outcomes, and food and nutrition security in low-income, ethnically diverse, at-risk women residing in Houston, Texas. Enrollment of participants will begin in pregnancy at the time of the first prenatal visit (as long as the first visit occurs before the end of the first trimester); each participant will be followed until 60 days post-partum (up to 11 months follow-up per participant).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
620
Inclusion Criteria
  • high-risk pregnant mothers receiving care at Texas Children's Health Plan (TCHP) managed care organizations in Houston, Texas
  • <20 weeks medically confirmed viable pregnancy
  • overweight/obese pre-pregnancy or at first trimester (self-report or measured BMI>30.0), and/or prior history of diabetes or gestational diabetes, and/or prior history of hypertension or pregnancy-induced hypertension
Exclusion Criteria
  • not a high-risk pregnant mother receiving care at Texas Children's Health Plan (TCHP) managed care organizations in Houston, Texas

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Absolute gestational weight gain (GWG) in poundsFrom the start of the third trimester of pregnancy to the end of the third trimester of pregnancy (3 months)
Excess gestational weight gain (EGWG) in poundsFrom the start of the third trimester of pregnancy to the end of the third trimester of pregnancy (3 months)
Secondary Outcome Measures
NameTimeMethod
Number of participants diagnosed with gestational diabetesFrom the time of enrollment until the time of birth (up to 9 months)
Infant birth weightat the time of birth
Number of participants diagnosed with pregnancy-induced hypertensionFrom the time of enrollment until the time of birth (up to 9 months)
Number of participants with pre-term birth (<37 weeks)at the time of birth

Trial Locations

Locations (1)

The University of Texas Health Science Center at Houston

🇺🇸

Houston, Texas, United States

The University of Texas Health Science Center at Houston
🇺🇸Houston, Texas, United States
Shreela Sharma, PhD
Contact
(713) 500-9344
Shreela.V.Sharma@uth.tmc.edu
Naomi Tice, MPH
Contact
(713) 500-9000
Naomi.Tice@uth.tmc.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.